BUDESONIDE 64mcg NASAL SPRAY (Benacort®)
Clinical Indication
Allergic Rhinitis
Comments
Both branded and Generic preparations have a DO NOT PRESCRIBE classification in LLR
Date of classification
February 2018
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.